These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20977452)

  • 1. Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis.
    Polito F; Bitto A; Irrera N; Squadrito F; Fazzari C; Minutoli L; Altavilla D
    Br J Pharmacol; 2010 Nov; 161(5):1002-11. PubMed ID: 20977452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis.
    Pallio G; Bitto A; Pizzino G; Galfo F; Irrera N; Minutoli L; Arcoraci V; Squadrito G; Macrì A; Squadrito F; Altavilla D
    Eur J Pharmacol; 2016 Oct; 789():152-162. PubMed ID: 27450484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.
    Altavilla D; Minutoli L; Polito F; Irrera N; Arena S; Magno C; Rinaldi M; Burnett BP; Squadrito F; Bitto A
    Br J Pharmacol; 2012 Sep; 167(1):95-108. PubMed ID: 22471974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages.
    Altavilla D; Squadrito F; Bitto A; Polito F; Burnett BP; Di Stefano V; Minutoli L
    Br J Pharmacol; 2009 Aug; 157(8):1410-8. PubMed ID: 19681869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis.
    Bitto A; Minutoli L; David A; Irrera N; Rinaldi M; Venuti FS; Squadrito F; Altavilla D
    Crit Care; 2012 Feb; 16(1):R32. PubMed ID: 22356547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavocoxid inhibits phospholipase A2, peroxidase moieties of the cyclooxygenases (COX), and 5-lipoxygenase, modifies COX-2 gene expression, and acts as an antioxidant.
    Burnett BP; Bitto A; Altavilla D; Squadrito F; Levy RM; Pillai L
    Mediators Inflamm; 2011; 2011():385780. PubMed ID: 21765617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual inhibitor of cyclooxygenase and 5-lipoxygenase protects against kainic acid-induced brain injury.
    Minutoli L; Marini H; Rinaldi M; Bitto A; Irrera N; Pizzino G; Pallio G; Calò M; Adamo EB; Trichilo V; Interdonato M; Galfo F; Squadrito F; Altavilla D
    Neuromolecular Med; 2015 Jun; 17(2):192-201. PubMed ID: 25893744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with either COX-2 inhibitor or 5-LOX inhibitor causes no compensation between COX-2 pathway and 5-LOX pathway in chronic aluminum overload-induced liver injury in rats.
    Xia H; He Q; Wang H; Wang Y; Yang Y; Li Y; Zhang J; Chen Z; Yang J
    Fundam Clin Pharmacol; 2019 Oct; 33(5):535-543. PubMed ID: 30903708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
    Kong W; Hooper KM; Ganea D
    Brain Behav Immun; 2016 Mar; 53():59-71. PubMed ID: 26541818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
    Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
    J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
    Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
    Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase.
    Knab LM; Grippo PJ; Bentrem DJ
    World J Gastroenterol; 2014 Aug; 20(31):10729-39. PubMed ID: 25152576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclooxygenase-2 reduces the protective effect of hepatocyte growth factor in experimental pancreatitis.
    Warzecha Z; Dembiński A; Ceranowicz P; Konturek S; Tomaszewska R; Stachura J; Nakamura T; Konturek PC
    Eur J Pharmacol; 2004 Feb; 486(1):107-19. PubMed ID: 14751415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid peroxidation inhibition reduces NF-kappaB activation and attenuates cerulein-induced pancreatitis.
    Altavilla D; Famulari C; Passaniti M; Campo GM; Macrì A; Seminara P; Marini H; Calò M; Santamaria LB; Bono D; Venuti FS; Mioni C; Leone S; Guarini S; Squadrito F
    Free Radic Res; 2003 Apr; 37(4):425-35. PubMed ID: 12747737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of zileuton and montelukast in mouse experimental spinal cord injury.
    Genovese T; Rossi A; Mazzon E; Di Paola R; Muià C; Caminiti R; Bramanti P; Sautebin L; Cuzzocrea S
    Br J Pharmacol; 2008 Feb; 153(3):568-82. PubMed ID: 18059327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavocoxid, dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, exhibits neuroprotection in rat model of ischaemic stroke.
    Singh DP; Chopra K
    Pharmacol Biochem Behav; 2014 May; 120():33-42. PubMed ID: 24561313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR.
    Meshram MA; Bhise UO; Makhal PN; Kaki VR
    Eur J Med Chem; 2021 Dec; 225():113804. PubMed ID: 34479036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavocoxid, a nutraceutical approach to blunt inflammatory conditions.
    Bitto A; Squadrito F; Irrera N; Pizzino G; Pallio G; Mecchio A; Galfo F; Altavilla D
    Mediators Inflamm; 2014; 2014():790851. PubMed ID: 25242871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis.
    Minutoli L; Altavilla D; Marini H; Passaniti M; Bitto A; Seminara P; Venuti FS; Famulari C; Macrì A; Versaci A; Squadrito F
    Life Sci; 2004 Oct; 75(24):2853-66. PubMed ID: 15454338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.